These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10136547)

  • 41. Antimicrobial formulary management: a case study in a teaching hospital.
    Wright DB
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):27S-31S. PubMed ID: 2011570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inventory management to reduce costs: a case study.
    Wilson S
    Hosp Pharm; 1995 Sep; 30(9):759-61, 765-6. PubMed ID: 10151280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
    Caldwell RD; Davis SK
    Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiulcer prescribing program in a state correctional system.
    Keith MR; Cason DM; Helling DK
    Ann Pharmacother; 1994 Jun; 28(6):792-6. PubMed ID: 7919571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic substitution of cimetidine for nizatidine was not associated with an increase in healthcare utilization.
    Good CB; Fultz SL; Trilli L; Etchason J
    Am J Manag Care; 2000 Oct; 6(10):1141-6. PubMed ID: 11184669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization.
    Brufsky JW; Ross-Degnan D; Calabrese D; Gao X; Soumerai SB
    Med Care; 1998 Mar; 36(3):321-32. PubMed ID: 9520957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Documentation of clinical interactions: quality of care issues and economic considerations in critical care pharmacy.
    Bearce WC; Willey GA; Fox RL; Coleman LT
    Hosp Pharm; 1988 Oct; 23(10):883-4, 886, 889-90. PubMed ID: 10290109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bid purchasing of pharmaceuticals.
    Swift RG; Ryan MR
    Am J Hosp Pharm; 1978 Nov; 35(11):1390-2. PubMed ID: 707509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reducing waste: a significant cost containment measure in an i.v. additive program.
    Coppola PA; Cassidy AP
    Hosp Pharm; 1987 Dec; 22(12):1215-6, 1246. PubMed ID: 10285376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comments on therapeutic interchange of histamine H2-receptor antagonists.
    Am J Hosp Pharm; 1990 Mar; 47(3):523-4. PubMed ID: 1969229
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A practical approach to achieving a $950,000 cost savings from a joint anesthesia-pharmacy program.
    Durfee DD
    Hosp Pharm; 1995 Nov; 30(11):957-8, 961-3. PubMed ID: 10152916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Savings achieved through use of a less concentrated amino acid solution.
    Ivey MF; Baluch W; Mueller W
    Am J Hosp Pharm; 1979 Jan; 36(1):57-9. PubMed ID: 103434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reducing the number of formulary theophylline preparations.
    Anandan JV
    Am J Hosp Pharm; 1981 Apr; 38(4):511-3. PubMed ID: 7282676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Change in prescribing patterns of intravenous histamine2-receptor antagonists results in significant cost savings without adversely affecting patient care.
    Fudge KA; Moore KA; Schneider DN; Sherrin TP; Wellman GS
    Ann Pharmacother; 1993 Feb; 27(2):232-7. PubMed ID: 8094986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bar-code technology applied to drug-use evaluation.
    Zarowitz BJ; Petitta A; Mlynarek M; Touchette M; Peters M; Long P; Patel R
    Am J Hosp Pharm; 1993 May; 50(5):935-9. PubMed ID: 8099468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A vancomycin drug use evaluation and economic analysis in a cancer treatment centre.
    Dranitsaris G; Pilla NJ; McGreer A
    Can J Hosp Pharm; 1994 Apr; 47(2):59-64. PubMed ID: 10134128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Total formulary review--the easy way.
    Chase K; Meyer JD; Kelly WN
    Hosp Pharm; 1984 Mar; 19(3):159-62. PubMed ID: 10265845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost of implementing and maintaining a hospital-pharmacy-based online literature search system.
    Souney PF; Churchill WW; Kaul AF
    Am J Hosp Pharm; 1985 Nov; 42(11):2496-8. PubMed ID: 4073067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.